(3S,4R)-4-(4-Fluorophenyl)piperidin-3-ol, also known as (3S,4R)-(-)-4-(4-Fluorophenyl)-3-(hydroxymethyl)piperidine, is a chiral piperidine derivative characterized by a fluorophenyl substituent and a hydroxymethyl group on the heterocyclic ring. It is a white to off-white crystalline powder with a molecular formula of C12H16FNO. This compound is a crucial chiral building block in pharmaceutical synthesis. Its primary and well-documented application is as a key intermediate in the production of the antidepressant drug Paroxetine. Paroxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat major depressive disorder, anxiety disorders, and other conditions. The specific stereochemistry of this intermediate is essential for the biological activity of the final API. As a high-value chiral synthon, it is typically produced via asymmetric synthesis or chiral resolution to obtain the desired (3S,4R) enantiomer. Its synthesis and purification are critical steps in the manufacturing process of Paroxetine, highlighting its importance in the fine chemical and pharmaceutical industries.